PT Hetzer Medical Indonesia Tbk (IDX:MEDS)

IDX:MEDS Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-8,534	-3,570	237.06	26,631	37,962
Depreciation & Amortization	4,569	4,228	2,969	1,728	684.44
Other Operating Activities	6,195	2,495	-16,230	-14,876	10,034
Operating Cash Flow	2,230	3,152	-13,023	13,484	48,681
Operating Cash Flow Growth	-29.25%	-	-	-72.30%	-
Capital Expenditures	-275.84	-6,084	-17,971	-27,008	-7,376
Sale of Property, Plant & Equipment	636.94	-	243.24	1	-
Cash Acquisitions	-	-3.78	-	-	-
Other Investing Activities	-	-	-	-712.5	-
Investing Cash Flow	361.09	-6,088	-17,728	-27,719	-7,376
Long-Term Debt Issued	-	-	-	11,200	1,100
Short-Term Debt Repaid	-	-	-	-2,100	-74.45
Long-Term Debt Repaid	-2,777	-2,486	-2,118	-133.69	-
Total Debt Repaid	-2,777	-2,486	-2,118	-2,234	-74.45
Net Debt Issued (Repaid)	-2,777	-2,486	-2,118	8,966	1,026
Issuance of Common Stock	-	-	36,830	-	-
Common Dividends Paid	-	-	-	-7,200	-29,000
Other Financing Activities	-247.5	725	-	-	-
Financing Cash Flow	-3,025	-1,761	34,712	1,766	-27,974
Net Cash Flow	-433.48	-4,696	3,960	-12,469	13,331
Free Cash Flow	1,954	-2,932	-30,995	-13,524	41,305
Free Cash Flow Margin	30.58%	-12.90%	-82.13%	-17.84%	47.05%
Free Cash Flow Per Share	1.25	-1.88	-22.57	-10.82	33.04
Cash Interest Paid	482.4	663.42	759.2	180.42	10.1
Cash Income Tax Paid	-2,287	-	1,972	16,403	169.09
Levered Free Cash Flow	4,653	7,135	-35,144	-19,723	33,244
Unlevered Free Cash Flow	4,954	7,550	-34,670	-19,610	33,250
Change in Net Working Capital	-6,082	-11,033	22,514	15,620	-9,542

Updated Oct 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.